Compared to Estimates, Amicus Therapeutics (FOLD) Q3 Earnings: A Look at Key Metrics

Amicus Therapeutics (FOLD) reported $169.06 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 19.5%. EPS of $0.17 for the same period compares to $0.10 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $164.76 million, representing a surprise of +2.61%. The company delivered an EPS surprise of +41.67%, with the consensus EPS estimate being $0.12. While investors closely watch year-over-year changes in headline numbers -- revenue ...